Literature DB >> 33886000

Identifying a role for the interaction of homocysteine and copper in promoting cardiovascular-related damage.

Megha Gupta1, Jiries Meehan-Atrash1, Robert M Strongin2.   

Abstract

Observations that copper and homocysteine levels are simultaneously elevated in patients with cardiovascular disease has generated interest in investigating the interactions between copper and homocysteine. Several prior studies have shown that complexes of copper and homocysteine are toxic, leading to cardiovascular damage in vitro. It is not clear, however, why related effects do not occur with other structurally similar, more abundant cellular thiols such as glutathione and cysteine. Herein, a mechanism for a selective redox interaction between copper and homocysteine is demonstrated. It involves a kinetically favored intramolecular hydrogen atom transfer that results in an alpha-amino carbon-centered radical known to promote biomolecular damage.

Entities:  

Keywords:  Alpha carbon radical; Cardiovascular disease; Copper; Diketopiperazine; Homocysteine; Hydrogen atom transfer; Thiyl radical

Mesh:

Substances:

Year:  2021        PMID: 33886000     DOI: 10.1007/s00726-021-02979-9

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  23 in total

1.  Nontraditional risk factors and biomarkers for cardiovascular disease: mechanistic, research, and clinical considerations for youth: a scientific statement from the American Heart Association.

Authors:  Prabhakaran Babu Balagopal; Sarah D de Ferranti; Stephen Cook; Stephen R Daniels; Samuel S Gidding; Laura L Hayman; Brian W McCrindle; Michele L Mietus-Snyder; Julia Steinberger
Journal:  Circulation       Date:  2011-05-09       Impact factor: 29.690

Review 2.  The evolution and refinement of traditional risk factors for cardiovascular disease.

Authors:  Emil M deGoma; Joshua W Knowles; Fabio Angeli; Matthew J Budoff; Daniel J Rader
Journal:  Cardiol Rev       Date:  2012 May-Jun       Impact factor: 2.644

3.  The metal-catalyzed oxidation of methionine in peptides by Fenton systems involves two consecutive one-electron oxidation processes.

Authors:  J Hong; C Schöneich
Journal:  Free Radic Biol Med       Date:  2001-12-01       Impact factor: 7.376

4.  Homocysteine promotes the LDL oxidase activity of ceruloplasmin.

Authors:  M Exner; M Hermann; R Hofbauer; B Hartmann; S Kapiotis; B Gmeiner
Journal:  FEBS Lett       Date:  2002-11-20       Impact factor: 4.124

5.  Cardiovascular disease: A global problem extending into the developing world.

Authors:  Temilolu Olayinka Aje; Michael Miller
Journal:  World J Cardiol       Date:  2009-12-31

Review 6.  Nontraditional risk factors for cardiovascular disease in diabetes.

Authors:  V Fonseca; C Desouza; S Asnani; I Jialal
Journal:  Endocr Rev       Date:  2004-02       Impact factor: 19.871

7.  Copper-homocysteine complexes and potential physiological actions.

Authors:  Margarita D Apostolova; Panayot R Bontchev; Bojidarka B Ivanova; Wendy R Russell; Dimiter R Mehandjiev; John H Beattie; Choudomir K Nachev
Journal:  J Inorg Biochem       Date:  2003-07-01       Impact factor: 4.155

Review 8.  Homocysteine, iron and cardiovascular disease: a hypothesis.

Authors:  Joseph E Baggott; Tsunenobu Tamura
Journal:  Nutrients       Date:  2015-02-06       Impact factor: 5.717

9.  Demethylation of methionine and keratin damage in human hair.

Authors:  Kamila Borowczyk; Joanna Suliburska; Hieronim Jakubowski
Journal:  Amino Acids       Date:  2018-02-26       Impact factor: 3.520

View more
  2 in total

1.  Lysosome-Targeting Fluorescence Sensor for Sequential Detection and Imaging of Cu2+ and Homocysteine in Living Cells.

Authors:  Lihua Liu; Hongfei Duan; Haohui Wang; Jieru Miao; Zhihui Wu; Chenxi Li; Yan Lu
Journal:  ACS Omega       Date:  2022-09-14

2.  Homocysteine and copper ions: is their interaction responsible for cardiovascular-related damage?

Authors:  Dimitrios Tsikas
Journal:  Amino Acids       Date:  2021-05-29       Impact factor: 3.520

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.